IFLR1000

McKesson Corporation €407.5 million acquisition of UDG's pharmaceutical business

18/9/2015
Private acquisition
Select tab

€ 407.5 million

$ 437.561 million

Announced

18/9/2015

Overview:

  • McKesson Corporation has acquired UDG's Irish pharmaceutical business for €407.5 million.
  • The divestment is part of UDG's strategy to focus on international healthcare services business and the company will use the proceeds to pay down debt.
  • The deal includes United Drug Supply Chain Services, United Drug Sangers, TCP Group and MASTAUDG Healthcare.

Sam Duke - Editor

Jurisdiction:

Ireland

Deal type:

Private acquisition

Practice area:

M&A

Industry sector:

Pharmaceuticals and life sciences

Firms:
A&L Goodbody

Party: UDG Healthcare (Seller)

Lawyers: Charlie Carroll, David Widger

Mason Hayes & Curran

Party: McKesson Corporation (Acquirer)

Lawyer: David O'Donnell

Related deals